Back
Results - Announcements
Sales rise 25.29% to Rs 125.55 crore
Beta Drugs consolidated net profit rises 35.04% in the June 2026 quarter
20-Jul-2026, 12:51
Net profit of Beta Drugs rose 35.04% to Rs 15.80 crore in the quarter ended June 2026 as against Rs 11.70 crore during the previous quarter ended June 2025. Sales rose 25.29% to Rs 125.55 crore in the quarter ended June 2026 as against Rs 100.21 crore during the previous quarter ended June 2025.
Net profit of Beta Drugs rose 35.04% to Rs 15.80 crore in the quarter ended June 2026 as against Rs 11.70 crore during the previous quarter ended June 2025. Sales rose 25.29% to Rs 125.55 crore in the quarter ended June 2026 as against Rs 100.21 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 125.55 | 100.21 | 25 |
| OPM % | 21.80 | 19.66 | - |
| PBDT | 26.39 | 19.37 | 36 |
| PBT | 22.04 | 15.65 | 41 |
| NP | 15.80 | 11.70 | 35 |
Powered by Capital Market - Live News